Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke

Stroke

Volumn 44, Issue 5, 2013, Pages 1389-1395

  Kimberly, W Taylor ^a,b   Wang, Yu ^b   Pham, Ly ^a   Furie, Karen L ^c   Gerszten, Robert E ^b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

cerebrospinal fluid; liquid chromatography; mass spectrometry; metabolomics; transient ischemic attack stroke

Indexed keywords

BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RAT; TANDEM MASS SPECTROMETRY;

ADULT; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; RATS; RATS, WISTAR; STROKE;

EID: 84876873082     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000397     Document Type: Article

References (34)

1. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes. 2009;58:2429-2443.
2. Lewis GD, Asnani A, Gerszten RE. Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol. 2008;52:117-123.
3. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature. 2008;455:1054-1056.
4. Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;134:714-717.
5. Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, et al. Metabolic signatures of exercise in human plasma. Sci Transl Med. 2010;2:33ra37.
6. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, et al. Metabolomic identifcation of novel biomarkers of myocardial ischemia. Circulation. 2005;112:3868-3875.
7. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, et al. Metabolite profling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest. 2008;118:3503-3512.
8. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311-326.
9. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448-453.
10. Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, et al. Metabolite profling identifes pathways associated with metabolic risk in humans. Circulation. 2012;125:2222-2231.
11. Kimberly WT. Biomarkers in neurocritical care. Neurotherapeutics. 2012;9:17-23.
12. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology. 2009;73:393-399.
13. Kernagis DN, Laskowitz DT. Evolving role of biomarkers in acute cere-brovascular disease. Ann Neurol. 2012;71:289-303.
14. Tatlisumak T, Fisher M. Handbook of Experimental Neurology: Methods and Techniques in Animal Research. Cambridge, NY: Cambridge University Press; 2006.
15. Sicard KM, Fisher M. Animal models of focal brain ischemia. Exp Transl StrokeMed. 2009;1:7.
16. Sharma AK, Schultze AE, Cooper DM, Reams RY, Jordan WH, Snyder PW. Development of a percutaneous cerebrospinal fuid collection technique in F-344 rats and evaluation of cell counts and total protein concentrations. Toxicol Pathol. 2006;34:393-395.
17. Benedek A, Móricz K, Jurányi Z, Gigler G, Lévay G, Hársing LG Jr, et al. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res. 2006;1116:159-165.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R StatistSoc B. 1995;57:289-300.
19. Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37:W652-W660.
20. Brosnan JT, Brosnan ME. Branched-chain amino acids: enzyme and substrate regulation. J Nutr. 2006;136:207S-211S.
21. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52:280-284.
22. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper-glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
23. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet. 1999;353:376-377.
24. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem. 2006;78:567-574.
25. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7:915-926.
26. Reeves MJ, Lisabeth LD. The confounding issue of sex and stroke. Neurology. 2010;74:947-948.
27. Nawabi MD, Block KP, Chakrabarti MC, Buse MG. Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J Clin Invest. 1990;85:256-263.
28. Holecek M. Leucine metabolism in fasted and tumor necrosis factor-treated rats. Clin Nutr. 1996;15:91-93.
29. Holecek M. Relation between glutamine, branched-chain amino acids, and protein metabolism. Nutrition. 2002;18:130-133.
30. Huang Y, Zhou M, Sun H, Wang Y. Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res. 2011;90:220-223.
31. Hutson SM, Lieth E, LaNoue KF. Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr. 2001;131:846S-850S.
32. Fernstrom JD. Branched-chain amino acids and brain function. J Nutr. 2005;135:1539S-1546S.
33. Hoffmann U, Lee JH, Qin T, Eikermann-Haerter K, Ayata C. Gabapentin reduces infarct volume but does not suppress peri-infarct depolarizations. J Cereb Blood Flow Metab. 2011;31:1578-1582.
34. Jung JY, Lee HS, Kang DG, Kim NS, Cha MH, Bang OS, et al. 1H-NMR-based metabolomics study of cerebral infarction. Stroke. 2011;42:1282-1288.